• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 10-Q filed by IO Biotech Inc.

    5/14/25 8:54:06 AM ET
    $IOBT
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $IOBT alert in real time by email

    Unavailable

    Get the next $IOBT alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $IOBT

    DatePrice TargetRatingAnalyst
    11/30/2021$21.00Overweight
    Morgan Stanley
    11/30/2021Outperform
    Cowen & Co.
    11/30/2021$20.00Buy
    Jefferies
    More analyst ratings

    $IOBT
    SEC Filings

    See more
    • SEC Form EFFECT filed by IO Biotech Inc.

      EFFECT - IO Biotech, Inc. (0001865494) (Filer)

      6/12/25 12:15:09 AM ET
      $IOBT
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • SEC Form 8-K filed by IO Biotech Inc.

      8-K - IO Biotech, Inc. (0001865494) (Filer)

      6/9/25 4:58:48 PM ET
      $IOBT
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • SEC Form 8-K filed by IO Biotech Inc.

      8-K - IO Biotech, Inc. (0001865494) (Filer)

      6/4/25 8:33:10 AM ET
      $IOBT
      Biotechnology: Pharmaceutical Preparations
      Health Care

    $IOBT
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Morgan Stanley initiated coverage on IO Biotech with a new price target

      Morgan Stanley initiated coverage of IO Biotech with a rating of Overweight and set a new price target of $21.00

      11/30/21 7:56:32 AM ET
      $IOBT
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Cowen & Co. initiated coverage on IO Biotech

      Cowen & Co. initiated coverage of IO Biotech with a rating of Outperform

      11/30/21 7:16:27 AM ET
      $IOBT
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Jefferies initiated coverage on IO Biotech with a new price target

      Jefferies initiated coverage of IO Biotech with a rating of Buy and set a new price target of $20.00

      11/30/21 6:57:41 AM ET
      $IOBT
      Biotechnology: Pharmaceutical Preparations
      Health Care